Company faces setback as EPO revokes patent for a C1-esterase inhibitor treatment | Patent aims at preventing ...

Skilled in microbiome, medical devices and next generation diagnostics, the new partner is skilled in creating IP strategies ...

29 October 2024 A federal jury finds Masimo’s smartwatches infringe Apple’s blood oxygen patents | Decision results in an ...

Case concerns allegations that ex-senior vice president of business development at Skye Orthobiologics misappropriated ...

Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | ...

Two large teams leave Locke Lord following Troutman Pepper merger | Buchanan opens Chicago office with a large life sciences ...

12 December 2024 Firm expands its Mechanical & Electromechanical Technologies Practice with latest addition | Partner brings ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne Kessler.